Ms. Kerri V. Woelfle, FNP Clinical Nurse Specialist - Family Health Medicare: Medicare Enrolled Practice Location: 39000 Bob Hope Dr, Cardiology Department, Rancho Mirage, CA 92270 Phone: 760-340-3911 |
Barbara Bigelow, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 39000 Bob Hope Dr, Rancho Mirage, CA 92270 Phone: 760-340-3911 |
Kari Moeller, FNP Clinical Nurse Specialist - Family Health Medicare: Accepting Medicare Assignments Practice Location: 72047 Dinah Shore Dr Ste C4, Rancho Mirage, CA 92270 Phone: 760-770-7600 Fax: 760-770-0500 |
News Archive
A new study led by American Cancer Society researchers in collaboration with leading experts concludes that physical activity should be routinely assessed during the doctor-patient encounter, and that clinicians should design in collaboration with their patients a detailed physical activity plan with goals that should be set and monitored.
Scientists at The Scripps Research Institute have identified a new cellular pathway that is affected in cystinosis, a rare genetic disorder that can result in eye and kidney damage.
Researchers at Signature Genomic Laboratories, which performs diagnostic genetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities, recently showed that microarray analysis can identify small DNA alterations in individuals with Pitt-Hopkins syndrome, a rare and poorly characterized genetic disorder.
Johns Hopkins scientists have been awarded a $3.7 million grant from the National Institutes of Health (NIH) to learn more about the nerve and muscle-wasting disease amyotrophic lateral sclerosis (ALS) using stem cells developed from ALS patients' skin. The award, given over a two-year span, will be shared with three other laboratories, including one at Harvard University and two at Columbia University.
Ipsen and Inspiration Biopharmaceuticals Inc. today announced they entered into an Asset Purchase Agreement (APA) whereby Baxter International (Baxter) agrees to acquire the worldwide rights to OBI-1, a recombinant porcine factor VIII (rpFVIII) in development for congenital hemophilia A with inhibitors and acquired hemophilia A, and Ipsen's industrial facility in Milford (Boston, MA).
› Verified 9 days ago